• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin.真性红细胞增多症骨髓体外红系集落形成。对促红细胞生成素的依赖性。
J Clin Invest. 1977 May;59(5):841-8. doi: 10.1172/JCI108706.
2
Endogenous erythroid colony-forming cells in fetal and newborn sheep.
J Lab Clin Med. 1979 Nov;94(5):699-707.
3
Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.真性红细胞增多症患者内源性红系集落测定及其临床意义。
Chin Med J (Engl). 2004 May;117(5):668-72.
4
Erythropoietin-independent erythroid colony formation by bone marrow progenitors exposed to interleukin-11 and interleukin-8.暴露于白细胞介素-11和白细胞介素-8的骨髓祖细胞形成不依赖促红细胞生成素的红系集落。
Exp Hematol. 2005 Nov;33(11):1299-308. doi: 10.1016/j.exphem.2005.07.002.
5
[In vitro study of erythroid precursors in Vaquez' disease (polycythemia vera). Evidence supporting 2 populations of erythroid stem cells in the bone marrow].
Nouv Rev Fr Hematol (1978). 1978;20(4):565-74.
6
[In vitro study of erythroblast precursors in Vasquez disease (polycythemia vera). Arguments in favor of a double population of erythroblastic stem cells in the bone marrow].[瓦氏病(真性红细胞增多症)中幼红细胞前体细胞的体外研究。支持骨髓中存在双群体幼红细胞干细胞的论据]
Nouv Rev Fr Hematol (1978). 1979 Jan 30;20(4):565-74.
7
Regulation of red blood cell production by erythropoietin: normal mouse marrow in vitro.
Exp Hematol. 1980 Oct;8(9):1114-22.
8
Combined effect of friend polycythemia virus and erythropoietin on erythroid burst formation in vitro.嗜亲红细胞病毒与促红细胞生成素对体外红系爆式集落形成的联合作用。
Exp Hematol. 1980;8 Suppl 8:248-58.
9
In polycythemia vera human interleukin 3 and granulocyte-macrophage colony-stimulating factor enhance erythroid colony growth in the absence of erythropoietin.
Exp Hematol. 1989 Oct;17(9):981-3.
10
Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin.真性红细胞增多症。正常和异常干细胞系对促红细胞生成素的体外反应。
J Clin Invest. 1978 Apr;61(4):1044-7. doi: 10.1172/JCI109003.

引用本文的文献

1
Quantification of IGF-1 Receptor May Be Useful in Diagnosing Polycythemia Vera-Suggestion to Be Added to Be One of the Minor Criterion.胰岛素样生长因子-1受体的定量检测可能有助于真性红细胞增多症的诊断——建议将其添加为次要标准之一。
PLoS One. 2016 Nov 3;11(11):e0165299. doi: 10.1371/journal.pone.0165299. eCollection 2016.
2
Targeting JAK2 in the therapy of myeloproliferative neoplasms.针对骨髓增殖性肿瘤的 JAK2 靶向治疗。
Expert Opin Ther Targets. 2012 Mar;16(3):313-24. doi: 10.1517/14728222.2012.662956. Epub 2012 Feb 17.
3
The JAK2(V617F) tyrosine kinase mutation in myeloproliferative disorders: Summary of published literature and a perspective.骨髓增殖性疾病中的 JAK2(V617F)酪氨酸激酶突变:文献综述及观点。
Curr Hematol Malig Rep. 2006 Jun;1(2):75-80. doi: 10.1007/s11899-006-0026-3.
4
Polycythemia vera.真性红细胞增多症。
Intern Emerg Med. 2010 Oct;5(5):375-84. doi: 10.1007/s11739-010-0369-6. Epub 2010 Mar 16.
5
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms.选择性 JAK1/2 抑制剂 INCB018424 的临床前特征:治疗骨髓增生性肿瘤的治疗意义。
Blood. 2010 Apr 15;115(15):3109-17. doi: 10.1182/blood-2009-04-214957. Epub 2010 Feb 3.
6
Myeloproliferative disorders.骨髓增殖性疾病
Blood. 2008 Sep 15;112(6):2190-8. doi: 10.1182/blood-2008-03-077966.
7
The chronic myeloproliferative disorders and mutation of JAK2: Dameshek's 54 year old speculation comes of age.慢性骨髓增殖性疾病与JAK2突变:达梅谢克54年前的推测已然成熟。
Best Pract Res Clin Haematol. 2007 Mar;20(1):5-12. doi: 10.1016/j.beha.2006.11.005.
8
Hematopoietic growth factors, signaling and the chronic myeloproliferative disorders.造血生长因子、信号传导与慢性骨髓增殖性疾病
Cytokine Growth Factor Rev. 2006 Dec;17(6):423-30. doi: 10.1016/j.cytogfr.2006.09.005. Epub 2006 Oct 20.
9
Recent advances in the bcr-abl negative chronic myeloproliferative diseases.bcr-abl阴性慢性骨髓增殖性疾病的最新进展
J Transl Med. 2006 Oct 11;4:41. doi: 10.1186/1479-5876-4-41.
10
The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation.JAK2 V617F突变发生于真性红细胞增多症的造血干细胞中,并倾向于向红系分化。
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6224-9. doi: 10.1073/pnas.0601462103. Epub 2006 Apr 7.

本文引用的文献

1
SOME PROPERTIES OF SERUM OBTAINED FROM RABBITS IMMUNIZED WITH HUMAN URINARY ERYTHROPOIETIN.
Blood. 1965 Feb;25:204-17.
2
USE OF THE HYPOXIA-INDUCED POLYCYTHEMIC MOUSE IN THE ASSAY AND STANDARDIZATION OF ERYTHROPOIETIN.低氧诱导性红细胞增多症小鼠在促红细胞生成素测定及标准化中的应用
J Lab Clin Med. 1963 Nov;62:743-52.
3
Studies on the response of hypoxia and relative hyperoxia in two polycythemia vera patients.两名真性红细胞增多症患者的低氧和相对高氧反应研究。
Indian J Med Res. 1967 Jun;55(6):543-8.
4
Erythropoietin excretion in normal man.正常人体内促红细胞生成素的排泄情况。
Blood. 1966 Sep;28(3):354-64.
5
The erythropoietin-hematocrit relationship in normal and polycythemic man: implications of marrow regulation.正常人和红细胞增多症患者中促红细胞生成素与血细胞比容的关系:骨髓调节的意义
Blood. 1968 Oct;32(4):597-609.
6
Response of polycythemia vera marrow to erythropoietin in vitro.
J Lab Clin Med. 1968 Jun;71(6):999-1012.
7
Comparative assay of erythropoietin standards.
Ann N Y Acad Sci. 1968 Mar 29;149(1):40-5. doi: 10.1111/j.1749-6632.1968.tb15133.x.
8
Androgen actions on erythropoiesis.雄激素对红细胞生成的作用。
Ann N Y Acad Sci. 1968 Mar 29;149(1):318-35. doi: 10.1111/j.1749-6632.1968.tb15167.x.
9
Tissue culture of bone marrow. 3. Myelostimulatory factors in serum of patients with myeloproliferative diseases.骨髓的组织培养。3. 骨髓增殖性疾病患者血清中的骨髓刺激因子。
Cancer. 1967 Oct;20(10):1679-88. doi: 10.1002/1097-0142(196710)20:10<1679::aid-cncr2820201018>3.0.co;2-j.
10
Letter: Bone-marrow responses in polycythemia vera.信函:真性红细胞增多症中的骨髓反应。
N Engl J Med. 1974 Jun 13;290(24):1382. doi: 10.1056/nejm197406132902419.

真性红细胞增多症骨髓体外红系集落形成。对促红细胞生成素的依赖性。

Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin.

作者信息

Zanjani E D, Lutton J D, Hoffman R, Wasserman L R

出版信息

J Clin Invest. 1977 May;59(5):841-8. doi: 10.1172/JCI108706.

DOI:10.1172/JCI108706
PMID:853125
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC372292/
Abstract

In the plasma clot culture system both normal and polycythemia vera (PV) bone marrow cells respond to erythropoietin (Ep), giving rise to large numbers of colonies of erythroid cells. In PV, but not in normal individuals, the marrow produced endogenous erythroid colonies (EED) in the absence of exogenous Ep. The number of EEC formed varied from patient to patient comprising anywhere from 6 to 29% of the total number of colonies formed in the presence of Ep. Exposure, before use in culture, of fetal calf serum and citrated bovine plasma to the gammaglobulin fraction of rabbit anti-Ep serum followed by treatment with goat anti-rabbit gamma-globulin re sulted in a significant decrease in EEC formation. Addition of anti-Ep directly to the culture medium produced similar results. In addition, the production of EEC in response to added Ep was inhibited in the presence of anti-Ep. Addition of very small doses of highly purified Ep to anti-Ep-treated cultures resulted in the reappearance of a significantnumber of EEC formation in PV may be due to a population of erythroid-committed precursors that are abnormally sensitive to small concentrations of Ep which may be present in fetal calf serum and citrated plasma. Although the mechanism of formation of these cells is not known, it appears that the final steps in the formation of red cells derived from this clone of precursors is subject to the usual Ep control.

摘要

在血浆凝块培养系统中,正常和真性红细胞增多症(PV)的骨髓细胞对促红细胞生成素(Ep)均有反应,可产生大量红系细胞集落。在PV患者中,而非正常个体中,骨髓在无外源性Ep的情况下可产生内源性红系集落(EEC)。所形成的EEC数量因患者而异,占在有Ep存在时所形成集落总数的6%至29%不等。在用于培养之前,将胎牛血清和枸橼酸化牛血浆暴露于兔抗Ep血清的γ球蛋白组分,随后用山羊抗兔γ球蛋白处理,导致EEC形成显著减少。将抗Ep直接添加到培养基中也产生了类似结果。此外,在有抗Ep存在的情况下,对添加的Ep产生反应的EEC生成受到抑制。向经抗Ep处理的培养物中添加极少量高度纯化的Ep,导致大量EEC重新出现。PV中EEC的形成可能归因于一群对胎牛血清和枸橼酸化血浆中可能存在的低浓度Ep异常敏感的红系定向前体细胞。尽管这些细胞的形成机制尚不清楚,但似乎源自该前体细胞克隆的红细胞形成的最终步骤受通常的Ep控制。